Published in Schizophr Bull on November 14, 2008
Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull (2014) 2.53
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population. JAMA Psychiatry (2016) 1.73
How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull (2009) 1.69
Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophr Res (2014) 1.58
Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr Res (2010) 1.55
Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry (2013) 1.53
Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research. Schizophr Bull (2012) 1.50
The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study. PLoS One (2015) 1.39
Examining potential contraindications for prolonged exposure therapy for PTSD. Eur J Psychotraumatol (2012) 1.31
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol (2012) 1.19
Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (2015) 1.14
Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry (2011) 1.06
Cortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions. Eur J Neurosci (2012) 1.04
The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull (2011) 0.98
Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment. Adv Med (2014) 0.97
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology (2010) 0.97
Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol (2013) 0.97
Time-lagged moment-to-moment interplay between negative affect and paranoia: new insights in the affective pathway to psychosis. Schizophr Bull (2013) 0.95
Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Schizophr Bull (2013) 0.94
An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. J Psychiatry Neurosci (2016) 0.90
Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia. Transl Psychiatry (2013) 0.89
Unmet needs in the management of schizophrenia. Neuropsychiatr Dis Treat (2014) 0.88
Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice. PLoS One (2012) 0.88
Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes. Schizophr Bull (2016) 0.87
Traumatic Stress Disorders and Risk of Subsequent Schizophrenia Spectrum Disorder or Bipolar Disorder: A Nationwide Cohort Study. Schizophr Bull (2016) 0.86
Re-evaluating the link between neuropsychiatric disorders and dysregulated adult neurogenesis. Nat Med (2016) 0.86
Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings. Hum Genet (2011) 0.86
Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review. Psychopharmacol Bull (2011) 0.85
Psychiatric comorbidity among adults with schizophrenia: a latent class analysis. Psychiatry Res (2013) 0.85
Obsessive compulsive symptoms in individuals at clinical risk for psychosis: association with depressive symptoms and suicidal ideation. Schizophr Res (2012) 0.85
Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice. Sci Rep (2015) 0.85
Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization. BMC Psychiatry (2013) 0.85
Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Ment Illn (2009) 0.83
Altered gamma oscillations during pregnancy through loss of δ subunit-containing GABA(A) receptors on parvalbumin interneurons. Front Neural Circuits (2013) 0.83
New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? Front Behav Neurosci (2010) 0.83
Amygdala NRG1-ErbB4 is critical for the modulation of anxiety-like behaviors. Neuropsychopharmacology (2014) 0.81
Prefrontal cortical GABA transmission modulates discrimination and latent inhibition of conditioned fear: relevance for schizophrenia. Neuropsychopharmacology (2014) 0.81
Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat (2014) 0.81
Exaggerated cue-induced reinstatement of cocaine seeking but not incubation of cocaine craving in a developmental rat model of schizophrenia. Psychopharmacology (Berl) (2012) 0.81
Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy. BMC Psychiatry (2015) 0.80
Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data. Neuropsychiatr Dis Treat (2015) 0.80
Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia. Neuropsychiatr Dis Treat (2013) 0.80
Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice. Pharmacol Biochem Behav (2014) 0.80
Self-awareness of functional impairment in individuals at clinical high-risk for psychosis. Early Interv Psychiatry (2013) 0.80
Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia. Neuropsychopharmacology (2015) 0.80
Genetic Approaches to Understanding Psychiatric Disease. Neurotherapeutics (2017) 0.80
Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: A phenomenological approach. World J Psychiatry (2013) 0.80
Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol Med (2014) 0.79
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry (2015) 0.79
A Transdiagnostic Network Approach to Psychosis. Schizophr Bull (2016) 0.79
The Effects of Acupuncture Treatment on Sleep Quality and on Emotional Measures among Individuals Living with Schizophrenia: A Pilot Study. Sleep Disord (2013) 0.79
Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry (2015) 0.79
Aberrant cerebellar connectivity in motor and association networks in schizophrenia. Front Hum Neurosci (2015) 0.79
Trauma exposure and PTSD in women with schizophrenia and coexisting substance use disorders: comparisons to women with severe depression and substance use disorders. Psychiatry Res (2014) 0.78
Schizophrenia and Suicide Attempts: Findings from a Representative Community-Based Canadian Sample. Schizophr Res Treatment (2016) 0.78
Depressed mood in individuals with schizophrenia: A comparison of retrospective and real-time measures. Psychiatry Res (2015) 0.78
Mechanisms Underlying Auditory Hallucinations-Understanding Perception without Stimulus. Brain Sci (2013) 0.78
Treatment of schizoaffective disorder. Psychiatry (Edgmont) (2009) 0.78
A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia. BMC Psychiatry (2015) 0.78
Interpersonal distances, coping strategies and psychopathology in patients with depression and schizophrenia. World J Psychiatry (2013) 0.78
Neuronal effects of nicotine during auditory selective attention in schizophrenia. Hum Brain Mapp (2015) 0.78
Integrating Insults: Using Fault Tree Analysis to Guide Schizophrenia Research across Levels of Analysis. Front Hum Neurosci (2016) 0.77
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder. Int J Neuropsychopharmacol (2010) 0.77
Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction. Int Rev Neurobiol (2015) 0.77
Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? Front Psychiatry (2015) 0.77
Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the Facial Action Coding System: a preliminary study. Neuropsychiatr Dis Treat (2012) 0.77
The relationship between somatic and cognitive-affective depression symptoms and error-related ERPs. J Affect Disord (2014) 0.77
Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand. Patient Prefer Adherence (2010) 0.77
Awareness and coping with emotion in schizophrenia: acceptability, feasibility and case illustrations. Clin Psychol Psychother (2013) 0.77
Type and timing of adverse childhood experiences differentially affect severity of PTSD, dissociative and depressive symptoms in adult inpatients. BMC Psychiatry (2016) 0.77
Is depression simply a nonspecific response to brain injury? Curr Psychiatry Rep (2013) 0.77
Eating disorders in schizophrenia: implications for research and management. Schizophr Res Treatment (2014) 0.76
Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms. Indian J Psychiatry (2013) 0.76
Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR₁₆) questionnaire in patients with schizophrenia. BMC Psychiatry (2014) 0.76
Association of stigma resistance with emotion regulation - functional magnetic resonance imaging and neuropsychological findings. Compr Psychiatry (2013) 0.76
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies. CNS Spectr (2014) 0.76
Schizophrenia comorbid with panic disorder: evidence for distinct cognitive profiles. Psychiatry Res (2012) 0.76
Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia. J Psychiatry Neurosci (2015) 0.76
Individual and contextual-level factors associated with continuity of care for adults with schizophrenia. Adm Policy Ment Health (2014) 0.76
Augmentation with antidepressants in schizophrenia treatment: benefit or risk. Neuropsychiatr Dis Treat (2015) 0.76
Mapping Depression in Schizophrenia: A Functional Magnetic Resonance Imaging Study. Schizophr Bull (2015) 0.76
Is body dysmorphic disorder associated with abnormal bodily self-awareness? A study using the rubber hand illusion. PLoS One (2014) 0.76
The Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosis. PLoS One (2014) 0.76
Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes. Int J Psychiatry Med (2015) 0.75
Evidence for a Shared Etiological Mechanism of Psychotic Symptoms and Obsessive-Compulsive Symptoms in Patients with Psychotic Disorders and Their Siblings. PLoS One (2015) 0.75
Effectiveness of rivastigmine on positive, negative, and cognitive symptoms of schizophrenia: a double-blind clinical trial. Ther Adv Psychopharmacol (2016) 0.75
Animal Models of Maternal Immune Activation in Depression Research. Curr Neuropharmacol (2016) 0.75
Addressing reverse inference in psychiatric neuroimaging: Meta-analyses of task-related brain activation in common mental disorders. Hum Brain Mapp (2017) 0.75
Trauma and the psychosis spectrum: A review of symptom specificity and explanatory mechanisms. Clin Psychol Rev (2016) 0.75
BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA. Schizophr Res Cogn (2014) 0.75
Hopes and Expectations Regarding Genetic Testing for Schizophrenia Among Young Adults at Clinical High-Risk for Psychosis. J Psychiatr Pract (2016) 0.75
Cross-Disorder Psychiatric Genomics. Curr Behav Neurosci Rep (2016) 0.75
Does Schizophrenia in Offspring Increase the Risk of Developing Alzheimer's Dementia. Dement Geriatr Cogn Dis Extra (2016) 0.75
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases. Front Neurosci (2016) 0.75
Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study. BMC Psychiatry (2016) 0.75
Lack of Gender-Related Differences in Childhood-Onset Schizophrenia. J Am Acad Child Adolesc Psychiatry (2016) 0.75
Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry (1995) 30.84
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry (1997) 8.01
Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry (2004) 5.10
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry (2005) 4.85
Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry (2005) 4.31
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2005) 3.93
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry (2003) 3.85
Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry (2004) 3.83
National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry (1991) 3.53
The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry (2007) 3.15
The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry (1988) 3.15
A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry (2001) 3.10
The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2006) 2.96
Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry (2006) 2.83
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74
Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67
The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull (2003) 2.67
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry (1997) 2.65
Psychiatric comorbidity: is more less? World Psychiatry (2004) 2.55
Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. Arch Gen Psychiatry (1984) 2.50
The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Aust N Z J Psychiatry (1998) 2.44
Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci (2003) 2.26
Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma--a critical review. Schizophr Bull (2006) 2.19
Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry (2004) 2.18
Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents. Am J Psychiatry (2000) 2.16
Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol (1998) 2.16
Posttraumatic stress disorder following recent-onset psychosis. An unrecognized postpsychotic syndrome. J Nerv Ment Dis (1991) 2.08
Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry (2008) 1.95
Depressive symptoms in schizophrenia. Am J Psychiatry (1999) 1.83
Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.75
Are schizophrenia and affective disorder related? A selective literature review. Am J Psychiatry (1992) 1.73
Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand (1999) 1.72
Depression in first-episode schizophrenia. Am J Psychiatry (1993) 1.71
Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry (2007) 1.67
Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry (1997) 1.67
Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry (2003) 1.59
Antipsychotic medication adherence in schizophrenia. Psychiatr Clin North Am (2007) 1.56
Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci (2005) 1.49
The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull (2000) 1.47
Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry (1993) 1.47
Panic attacks in chronic schizophrenia. Br J Psychiatry (1990) 1.46
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry (1988) 1.46
Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls. Schizophr Res (2005) 1.44
Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Can J Psychiatry (2006) 1.43
Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry (1998) 1.39
Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry (2003) 1.37
Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry (2002) 1.37
Trauma and posttraumatic stress disorder in people with schizophrenia. J Abnorm Psychol (2003) 1.36
Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res (2001) 1.36
The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry (1986) 1.36
Traumatic life events and PTSD among women with substance use disorders and schizophrenia. Psychiatr Serv (2003) 1.32
Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatr Scand (2005) 1.30
The classification of depressions: a review of contemporary confusion. Br J Psychiatry (1976) 1.30
Studies of depressive symptoms in schizophrenia. Br J Psychiatry (1981) 1.26
Obsessive-compulsive disorder in patients with first-episode schizophrenia. Am J Psychiatry (1999) 1.25
Understanding suicidal ideation in psychosis: findings from the Psychological Prevention of Relapse in Psychosis (PRP) trial. Acta Psychiatr Scand (2006) 1.22
Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. J Clin Psychiatry (2004) 1.21
Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet (2000) 1.20
Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry (2005) 1.19
Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry (2003) 1.18
Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci (1999) 1.17
Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry (1992) 1.17
The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry (1991) 1.17
Demoralization: its phenomenology and importance. Aust N Z J Psychiatry (2002) 1.16
Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res (2007) 1.16
Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. J Clin Psychiatry (2006) 1.16
Interpersonal trauma and posttraumatic stress disorder in patients with severe mental illness: demographic, clinical, and health correlates. Schizophr Bull (2004) 1.15
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry (2005) 1.13
Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis (1998) 1.12
Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry (1985) 1.11
"Akinetic depression" in schizophrenia. Arch Gen Psychiatry (1978) 1.10
Suicidality in schizophrenic patients with and without obsessive-compulsive disorder. Schizophr Res (2006) 1.10
Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull (1990) 1.10
Trauma exposure and posttraumatic stress disorder in psychosis: findings from a first-admission cohort. J Consult Clin Psychol (2002) 1.10
Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res (2004) 1.08
Detection and management of comorbidity in patients with schizophrenia. Psychiatr Clin North Am (2003) 1.08
A scale-free systems theory of motivation and addiction. Neurosci Biobehav Rev (2007) 1.07
Depression during the longitudinal course of schizophrenia. Schizophr Bull (1999) 1.07
Disorders of thought are severe mood disorders: the selective attention defect in mania challenges the Kraepelinian dichotomy a review. Schizophr Bull (2007) 1.06
Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry (1995) 1.06
Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med (1993) 1.06
Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res (2000) 1.06
Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms. Schizophr Res (2004) 1.06
Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull (2000) 1.04
Clinical profile of "schizo-obsessive" disorder: a comparative study. Compr Psychiatry (2007) 1.04
Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat (2007) 1.03
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. Br J Psychiatry (1979) 1.03
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry (2004) 1.03
Comorbid schizophrenia and substance abuse: a review of epidemiology and course. Am J Addict (2006) 1.03
Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry (1995) 1.00
Comorbidity in psychosis at first hospitalization. Am J Psychiatry (1993) 0.99
Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr Res (2000) 0.98
Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry (1990) 0.98
A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Schizophr Res (2007) 0.98
"Revealed" Depression and drug treatment for schizophrenia. Arch Gen Psychiatry (1981) 0.98
Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry (1998) 0.97
Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med (2012) 3.40
Why are community psychiatry services in Australia doing it so hard? Med J Aust (2007) 2.06
Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 2.02
Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci U S A (2002) 1.67
Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res (2007) 1.54
Prospective study of outcomes after reduction mammaplasty: long-term follow-up. Plast Reconstr Surg (2006) 1.53
Mindfulness training: an adjunctive role in the management of chronic illness? Med J Aust (2012) 1.44
Bipolar disorder: new understandings, emerging treatments. Med J Aust (2010) 1.38
A study of large-bowel volvulus in urban Australia. Can J Surg (2006) 1.38
Layer upon layer: thermoregulation in schizophrenia. Schizophr Res (2004) 1.33
A review of psychosocial outcomes for patients seeking cosmetic surgery. Plast Reconstr Surg (2004) 1.33
Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry (2013) 1.27
Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task. Neuroimage (2006) 1.21
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res (2006) 1.19
How do obese individuals perceive and respond to the different types of obesity stigma that they encounter in their daily lives? A qualitative study. Soc Sci Med (2011) 1.18
Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? Schizophr Bull (2010) 1.11
Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain Behav Immun (2012) 1.07
Inflammation and schizophrenia. Schizophr Bull (2013) 1.02
Do health beliefs and behaviors differ according to severity of obesity? A qualitative study of Australian adults. Int J Environ Res Public Health (2010) 1.01
Delusional versus nondelusional body dysmorphic disorder. Compr Psychiatry (2009) 0.99
Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Aust N Z J Psychiatry (2008) 0.98
Psychological distress (depression and anxiety) in people with head and neck cancers. Med J Aust (2010) 0.96
Serum clozapine levels: a review of their clinical utility. J Psychopharmacol (2003) 0.95
The Dysmorphic Concern Questionnaire: A screening measure for body dysmorphic disorder. Aust N Z J Psychiatry (2010) 0.95
Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Ann Emerg Med (2005) 0.94
Aging and cosmetic enhancement. Clin Interv Aging (2006) 0.94
The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Aust N Z J Psychiatry (2012) 0.94
The genomic psychiatry cohort: partners in discovery. Am J Med Genet B Neuropsychiatr Genet (2013) 0.94
A qualitative investigation of obese men's experiences with their weight. Am J Health Behav (2011) 0.93
Gender differences in premorbid adjustment of patients with first episode psychosis. Schizophr Res (2002) 0.89
Treating comorbid substance use disorders in schizophrenia. Int Rev Psychiatry (2010) 0.89
Antibiotic-associated psychosis during treatment of urinary tract infections: a systematic review. J Clin Psychopharmacol (2014) 0.86
Current visual scanpath research: a review of investigations into the psychotic, anxiety, and mood disorders. Compr Psychiatry (2011) 0.86
The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis (2013) 0.86
Controlled clinical trial of a self-management program for people with mental illness in an adult mental health service - the Optimal Health Program (OHP). Aust Health Rev (2012) 0.85
Body dysmorphic disorder, social anxiety and depressive symptoms in Chinese medical students. Soc Psychiatry Psychiatr Epidemiol (2009) 0.84
Systematic review of the efficacy of pre-surgical mind-body based therapies on post-operative outcome measures. Complement Ther Med (2013) 0.83
The role of psychotherapy in bipolar disorder. Med J Aust (2010) 0.83
Symptoms of disordered eating, body shape, and mood concerns in male and female Chinese medical students. Compr Psychiatry (2010) 0.81
An examination of delusional thinking and cognitive styles in body dysmorphic disorder. Aust N Z J Psychiatry (2010) 0.81
Signaling through the small G-protein Cdc42 is involved in insulin-like growth factor-I resistance in aging articular chondrocytes. J Orthop Res (2006) 0.81
A comparison of olanzapine versus risperidone for the treatment of schizophrenia: a meta-analysis of randomised clinical trials. Int J Psychiatry Clin Pract (2005) 0.81
Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Aust N Z J Psychiatry (2005) 0.79
Urinary tract infections in acute psychosis. J Clin Psychiatry (2014) 0.79
Pharmacological approaches to the management of schizophrenia. Med J Aust (2003) 0.79
Assessment of the catabolic effects of interleukin-1beta on proteoglycan metabolism in equine cartilage cocultured with synoviocytes. Am J Vet Res (2006) 0.78
Hospital admission for schizophrenia and bipolar disorder. BMJ (2011) 0.78
Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry (2014) 0.78
Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia. Ther Drug Monit (2003) 0.78
Own-body perception in body dysmorphic disorder. Cogn Neuropsychiatry (2013) 0.78
A systematic review of the recent quality of life studies in adult extremity sarcoma survivors. Sarcoma (2012) 0.78
Beyond Urinary Tract Infections (UTIs) and Delirium: A Systematic Review of UTIs and Neuropsychiatric Disorders. J Psychiatr Pract (2015) 0.77
Management of schizophrenia: clinical experience with asenapine. J Psychopharmacol (2013) 0.77
Bipolar mixed states: still mixed up? Curr Opin Psychiatry (2014) 0.77
A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol. BMC Psychiatry (2014) 0.77
A statewide evaluation system for early psychosis. Aust N Z J Psychiatry (2003) 0.76
Quantifying the accuracy of forensic examiners in the absence of a "gold standard". Law Hum Behav (2009) 0.76
Attachment Insecurity Predicts Punishment Sensitivity in Anorexia Nervosa. J Nerv Ment Dis (2016) 0.76
Differential white blood cell counts may predict urinary tract infection in acute non-affective psychosis. Schizophr Res (2013) 0.75
Early intervention in psychosis: evidence, evidence gaps, criticism and confusion. Aust N Z J Psychiatry (2012) 0.75
The effect of mindfulness training prior to total joint arthroplasty on post-operative pain and physical function: study protocol for a randomised controlled trial. Trials (2014) 0.75
In reply. Ann Emerg Med (2013) 0.75
How international are psychiatry journals? Lancet (2003) 0.75
Enhancing work-focused supports for people with severe mental illnesses in australia. Rehabil Res Pract (2012) 0.75
Body dysmorphic disorder--a fear of imagined ugliness. Aust Fam Physician (2003) 0.75
Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey. Clin Schizophr Relat Psychoses (2016) 0.75
Attitudes towards cosmetic surgery among university students. Med J Aust (2007) 0.75
Bipolar disorder in general practice: challenges and opportunities. Med J Aust (2010) 0.75
Echocardiographic monitoring for clozapine-associated cardiac toxicity--time for review? Med J Aust (2013) 0.75
Effect of fuel type on carbon monoxide accumulation in tents of varied design. Wilderness Environ Med (2013) 0.75
Determining the efficacy and tolerance of quetiapine extended release for the management of psychosis and accompanying acute behavioral disturbance in adult acute psychiatry. Ann Clin Psychiatry (2012) 0.75